Key insights
- Congressman Richard W. Allen sold shares in several major US companies including Abbott Laboratories, Ameriprise Financial, Intuit, Procter & Gamble, and S&P Global, as well as US Treasury Notes. The sales, ranging from $15,000 to $100,000 for stocks and up to $250,000 for Treasury Notes, were made through his investment firm. While the article notes some companies appear undervalued, the sales are attributed to the congressman's investment firm and do not necessarily reflect a
Richard W. Allen, the incumbent congressman from Georgia’s 12th congressional district, has recently sold a series of stocks, according to a recent congressional trade report. The stocks sold include those of Abbott Laboratories (NYSE:ABT), Ameriprise Financial (NYSE:AMP), Intuit Inc. (NASDAQ:INTU), Procter & Gamble Company (NYSE:PG), S&P Global Inc. (NYSE:SPGI), and US Treasury Notes.
The transactions, which occurred in mid-April, were reported in early May. The stocks were part of the portfolio of R.W. Allen & Associates, Inc., an investment firm owned by the congressman.
Abbott Laboratories, a leading medical devices and health care company, saw a sale amounting to a range of $15,001 to $50,000. The $157.65 billion healthcare giant currently trades at a P/E ratio of 25.41 and offers a dividend yield of 2.78%. According to InvestingPro analysis, Abbott appears undervalued at current levels and has maintained dividend payments for 56 consecutive years—a testament to its financial stability. Similarly, Intuit Inc., known for its financial and tax preparation software, Procter & Gamble, a multinational consumer goods corporation, and S&P Global, a company providing financial information and analytics, each saw sales within the same range.
Ameriprise Financial, a diversified financial services company, had a slightly higher sale, with the transaction value falling between $50,001 and $100,000.
The congressman also sold US Treasury Notes, with two separate sales each valued between $100,001 and $250,000. These notes, due in 2026 and 2028, are government securities with fixed interest rates.
All transactions were made through the investment vehicle R.W. Allen & Associates, Inc., located in the Augusta/Richmond area of Georgia.
The sale of these stocks does not necessarily reflect on the performance or future prospects of these companies. For deeper analysis, Abbott Laboratories is among the 1,400+ US equities covered by comprehensive Pro Research Reports, which transform complex Wall Street data into clear, actionable intelligence. Investors are advised to conduct their own research or consult with a financial advisor before making investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy. Get the bottom line for AMP plus thousands of other stocks and find your next hidden gem with massive upside.